QACS Achieves FDA Registration for FY 2025

QACS Ltd proudly announces its registration with the U.S. Food and Drug Administration (FDA) as an officially recognized FDA registered Lab for the statutory filing period applicable to U.S. Fiscal Year 2025, in accordance with Part 207 of Title 21 of the U.S. Code of Federal Regulations. This achievement reinforces QACS’s commitment to quality, compliance, and global standards in laboratory testing and regulatory services.

The FDA Establishment Identification (FEI) number, uniquely assigned to QACS, serves as an official identifier through which the FDA tracks inspections and verifies compliance of registered facilities under its jurisdiction. This recognition marks a major step for QACS, demonstrating not only regulatory alignment with the U.S. framework but also readiness to support partners and clients seeking market access in the United States.

Being an FDA registered Lab is a strong mark of credibility and reliability. It ensures that the laboratory operates under strict quality, safety, and documentation requirements that meet U.S. federal standards. For industries such as cosmetics, pharmaceuticals, medical devices, biocides, and food, this status offers confidence that their products are analyzed and verified in a facility compliant with one of the world’s most respected regulatory systems.

With this registration, QACS strengthens its global presence, providing enhanced regulatory support and testing services to manufacturers and exporters needing to comply with FDA requirements. This milestone underlines the company’s strategic focus on international regulatory compliance, data integrity, and continuous quality improvement, reaffirming QACS’s position as a trusted partner for safe, compliant, and high-quality products worldwide.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Check our Quality Management System